LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $61.95 million. The enterprise value is $57.63 million.
| Market Cap | 61.95M |
| Enterprise Value | 57.63M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Dec 1, 2026 |
Share Statistics
LifeVantage has 12.68 million shares outstanding. The number of shares has decreased by -3.35% in one year.
| Current Share Class | 12.53M |
| Shares Outstanding | 12.68M |
| Shares Change (YoY) | -3.35% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 20.87% |
| Owned by Institutions (%) | 45.28% |
| Float | 8.46M |
Valuation Ratios
The trailing PE ratio is 23.36 and the forward PE ratio is 15.03.
| PE Ratio | 23.36 |
| Forward PE | 15.03 |
| PS Ratio | 0.37 |
| Forward PS | 0.40 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | 7.34 |
| P/OCF Ratio | 4.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.29, with an EV/FCF ratio of 6.84.
| EV / Earnings | 21.90 |
| EV / Sales | 0.35 |
| EV / EBITDA | 8.29 |
| EV / EBIT | 13.87 |
| EV / FCF | 6.84 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.91 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.04 |
| Debt / FCF | 1.08 |
| Interest Coverage | 87.67 |
Financial Efficiency
Return on equity (ROE) is 8.19% and return on invested capital (ROIC) is 11.17%.
| Return on Equity (ROE) | 8.19% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | 11.17% |
| Return on Capital Employed (ROCE) | 10.45% |
| Weighted Average Cost of Capital (WACC) | 7.28% |
| Revenue Per Employee | $771,937 |
| Profits Per Employee | $12,202 |
| Employee Count | 223 |
| Asset Turnover | 2.85 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, LifeVantage has paid $920,000 in taxes.
| Income Tax | 920,000 |
| Effective Tax Rate | 25.27% |
Stock Price Statistics
The stock price has decreased by -28.16% in the last 52 weeks. The beta is 0.74, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -28.16% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 5.85 |
| Relative Strength Index (RSI) | 34.11 |
| Average Volume (20 Days) | 36,588 |
Short Selling Information
The latest short interest is 976,051, so 7.70% of the outstanding shares have been sold short.
| Short Interest | 976,051 |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 7.70% |
| Short % of Float | 11.53% |
| Short Ratio (days to cover) | 29.19 |
Income Statement
In the last 12 months, LifeVantage had revenue of $172.14 million and earned $2.72 million in profits. Earnings per share was $0.21.
| Revenue | 172.14M |
| Gross Profit | 131.77M |
| Operating Income | 4.30M |
| Pretax Income | 3.64M |
| Net Income | 2.72M |
| EBITDA | 7.19M |
| EBIT | 4.30M |
| Earnings Per Share (EPS) | $0.21 |
Balance Sheet
The company has $13.73 million in cash and $9.40 million in debt, with a net cash position of $4.32 million or $0.34 per share.
| Cash & Cash Equivalents | 13.73M |
| Total Debt | 9.40M |
| Net Cash | 4.32M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 33.26M |
| Book Value Per Share | 2.64 |
| Working Capital | 16.45M |
Cash Flow
In the last 12 months, operating cash flow was $13.08 million and capital expenditures -$4.37 million, giving a free cash flow of $8.71 million.
| Operating Cash Flow | 13.08M |
| Capital Expenditures | -4.37M |
| Depreciation & Amortization | 2.89M |
| Net Borrowing | n/a |
| Free Cash Flow | 8.71M |
| FCF Per Share | $0.69 |
Margins
Gross margin is 76.54%, with operating and profit margins of 2.50% and 1.58%.
| Gross Margin | 76.54% |
| Operating Margin | 2.50% |
| Pretax Margin | 2.12% |
| Profit Margin | 1.58% |
| EBITDA Margin | 4.18% |
| EBIT Margin | 2.50% |
| FCF Margin | 5.06% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 4.09%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 4.09% |
| Dividend Growth (YoY) | 11.43% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 95.65% |
| FCF Payout Ratio | 28.78% |
| Buyback Yield | 3.35% |
| Shareholder Yield | 7.32% |
| Earnings Yield | 4.28% |
| FCF Yield | 13.62% |
Analyst Forecast
The average price target for LifeVantage is $6.50, which is 33.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.50 |
| Price Target Difference | 33.06% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -5.95% |
| EPS Growth Forecast (3Y) | -26.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |